tiprankstipranks
Trending News
More News >
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market

Compare Nuvectis Pharma (NVCT) vs. Competitors

Compare
116 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nuvectis Pharma
$8.41
$215.42M
-6.37
49.11%
3 Buy
0 Hold
0 Sell
Strong Buy
Nkarta
$2.07
$147.03M
-1.49
-6.33%
4 Buy
1 Hold
0 Sell
Strong Buy
Orchestra BioMed Holdings
$4.46
$251.83M
-2.45
-15.37%
5 Buy
0 Hold
0 Sell
Strong Buy
Greenwich LifeSciences
$9.28
$405.80M
-20.01
142.87%
2 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners
$4.21
$168.11M
-2.21
-21.46%
2 Buy
0 Hold
0 Sell
Moderate Buy
Pyxis Oncology
$1.99
$123.91M
-1.25
38.19%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NVCT
Nuvectis Pharma
8.41
2.95
54.03%
NKTX
Nkarta
2.07
-0.42
-16.87%
OBIO
Orchestra BioMed Holdings
4.46
-0.98
-18.01%
GLSI
Greenwich LifeSciences
29.29
16.72
133.02%
MOLN
Molecular Partners
4.21
-1.60
-27.54%
PYXS
Pyxis Oncology
1.99
0.52
35.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts